ZEPBOUND™

Next-Generation Fat Loss, Backed by Science

Zepbound™ (tirzepatide) is the newest FDA-approved weight loss medication from Eli Lilly — and it’s showing exceptional results. Like Mounjaro®, it’s a dual-action GLP-1/GIP receptor agonist designed specifically for weight loss, not diabetes. Zepbound™ helps women lose weight more efficiently, especially in areas like the belly and chest, where stubborn fat tends to accumulate most.

We manage your prescription—book your consultation today.

The Benefits of Zepbound™

ZEPBOUND™ EFFECTS + BENEFITS:
  • Strong appetite suppression and fat reduction
  • Helps target visceral (dangerous) fat stores
  • Can improve blood sugar, inflammation, and cholesterol
  • Promotes long-term lifestyle changes by reducing cravings
  • Excellent option if you’ve plateaued on other plans

Request Appointment

Please select your gender:(Required)
MM slash DD slash YYYY
Time (Office Hours: 8:30 a.m.-5 p.m.)
:
This field is for validation purposes and should be left unchanged.

ABOUT OUR PROCESS

1. Initial Consultation

We begin with a private consultation, physical, and labs to determine if Zepbound™ is right for your goals and body chemistry.

2. Customized Program

We’ll create a plan around your schedule, activity level, and medical background — and help you stay ahead of any side effects.

3. Delivery & Treatment

Our team manages your Zepbound™ prescription via Lilly’s patient portal. The $499/month cost is billed by Lilly, while your $150/month fee with Aqua Vitae includes dosing guidance, check-ins, B-12 shots, and access to our care team whenever you need us.

4. Follow Up

We stay with you the entire journey, adjusting your plan and tracking your labs, weight, and results so you get the most out of your program.

Doctor’s Note: Dr. Menendez on GLP-1s

“By now, we have all heard that GLP-1 agonists are revolutionizing health, with their impressive benefits in weight loss and diabetes control. But studies show their impact goes far beyond that: lowering stroke and heart attack risk by 20%, improving liver function (FDA-approved for fatty liver disease in 2025), and even suggesting protection against dementia. Research also confirms GLP-1s reduce inflammation, support joint health, and guard against oxidative stress, cellular senescence, and inflammation — what scientists call the ‘Three Horsemen of Aging.’ These benefits occur independently of weight loss, which is why I personally take — and recommend — a low dose GLP-1 for overall health.”

WHAT OUR CLIENTS ARE SAYING

TREATMENT METHOD

Zepbound™ is administered once weekly or as prescribed by a health professional for optimal results.

Duration

Long or short-term use coupled with exercise, a low-calorie diet, and other behavioral changes and adjustments.

Administration

Administered subcutaneously in the abdomen, thigh, or upper arm weekly.

Effectiveness

Over the course of treatment, individuals have lost between 5 and 15% of their body weight. A small percentage has seen results up to 20% total body weight loss.

GLP-1 Management Plan

$150/mo

Access to medications like Ozempic, Wegovy, Mounjaro, or Zepbound Unlimited doctor visits Inbody Analysis Expert medical and nutritional guidance

RELATED ARTICLES

ZEPBOUND™ FAQS

Our team of clinical experts have answers.

Who is an ideal candidate for Zepbound™?

Zepbound™ is suited for adults with obesity (BMI over 30) or those who are overweight (BMI over 27) and have weight-related health issues.

How does Zepbound™ work?

Zepbound™ mimics a natural gut hormone that signals the brain to reduce appetite and control cravings. This helps lower food intake and supports lasting weight loss.

LET'S CREATE
PROGRESS TOGETHER

Have a question? Please fill out the form below and we will be in touch within 24 hours.

Please select your gender:(Required)
MM slash DD slash YYYY
Time (Office Hours: 8:30 a.m.-5 p.m.)
:
This field is for validation purposes and should be left unchanged.